Vertex Pharmaceuticals
VRTX
#151
Rank
HK$1.066 T
Marketcap
HK$4,208
Share price
0.42%
Change (1 day)
24.13%
Change (1 year)

P/S ratio for Vertex Pharmaceuticals (VRTX)

P/S ratio as of November 2026 (TTM): 10.5

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.72. At the end of 2026 the company had a P/S ratio of 9.87.

P/S ratio history for Vertex Pharmaceuticals from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20269.872.2%
20259.661.12%
20249.55-10.09%
202310.627.99%
20228.3012.49%
20217.38-25.49%
20209.90-27.3%
201913.6-1.82%
201813.9-8.89%
201715.241.87%
201610.7-64.24%
201530.0-39.33%
201449.5245.26%
201314.3140.39%
20125.9621.42%
20114.91-90.13%
201049.7-40.87%
200984.1243.25%
200824.557.95%
200715.5-28.9%
200621.817.27%
200518.6123.8%
20048.31-31.45%
200312.161.36%
20027.51-46.1%
200113.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.61-37.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
7.66-27.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.76-35.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.04-52.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.43-76.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
3.67-65.02%๐Ÿ‡บ๐Ÿ‡ธ USA